Is There a Minimally Invasive Day Case Operation to Treat LUTS Secondary to BPH and Avoid Sexual Dysfunction? UroLift A Case Report
Abstract A 75 year old Caucasian male with a prolonged history of lower urinary tract symptoms and sexual dysfunction was referred to the urology department. Assessment revealed a diagnosis of benign prostatic hypertrophy (BPH) and the patient was reassessed by flexible cystoscopy revealing a lar...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MRE Press
2018-01-01
|
| Series: | Journal of Men's Health |
| Online Access: | http://jomh.org/index.php/JMH/article/view/59 |
| _version_ | 1797326691254665216 |
|---|---|
| author | Antonio Devanti Bardoli Will Taylor Wasim Mahmalji Jon Cobley |
| author_facet | Antonio Devanti Bardoli Will Taylor Wasim Mahmalji Jon Cobley |
| author_sort | Antonio Devanti Bardoli |
| collection | DOAJ |
| description | Abstract
A 75 year old Caucasian male with a prolonged history of lower urinary tract symptoms and sexual dysfunction was referred to the urology department. Assessment revealed a diagnosis of benign prostatic hypertrophy (BPH) and the patient was reassessed by flexible cystoscopy revealing a large occlusive 80cc prostate. Baseline symptoms of BPH were measured using the International Prostate Symptom Score (IPSS), urinary function was quantified by measuring post void residual (PVR) volume and QMAX flow rates were also recorded. The patient underwent the Urolift procedure and urological parameters were reassessed at 4 months post-operatively. There was an improvement in the patients IPSS by 14 points (IPSS Before =22, at 4 months =8), with a reduction in quality of life by 3 points (QoL before = 5, at 4 months =2).PVR volume decreased by almost a third (29.4 %) (Before = 390ml, at 4 months = 275 ml) and QMAX improved by 8 ml/s (Before =14ml/s, at 4 months= 22ml/s). The patient reported a slight improvement in sexual function (IIEF-5 Before = 14, at 4 months = 15) and was very satisfied with the result. The improvement in IPSS, PVR volume and QMAX show Urolift is an appropriate treatment for symptomatic BPH. |
| first_indexed | 2024-03-08T06:27:53Z |
| format | Article |
| id | doaj.art-f606dba44541457d9f20182669ab0027 |
| institution | Directory Open Access Journal |
| issn | 1875-6859 |
| language | English |
| last_indexed | 2024-03-08T06:27:53Z |
| publishDate | 2018-01-01 |
| publisher | MRE Press |
| record_format | Article |
| series | Journal of Men's Health |
| spelling | doaj.art-f606dba44541457d9f20182669ab00272024-02-03T13:29:48ZengMRE PressJournal of Men's Health1875-68592018-01-01141Is There a Minimally Invasive Day Case Operation to Treat LUTS Secondary to BPH and Avoid Sexual Dysfunction? UroLift A Case ReportAntonio Devanti Bardoli0Will Taylor1Wasim Mahmalji2Jon Cobley3University of BirminghamDepartment of Urology, Hereford County Hospital, Wye Valley NHS TrustDepartment of Urology, Hereford County Hospital, Wye Valley NHS TrustDepartment of Urology, Hereford County Hospital, Wye Valley NHS TrustAbstract A 75 year old Caucasian male with a prolonged history of lower urinary tract symptoms and sexual dysfunction was referred to the urology department. Assessment revealed a diagnosis of benign prostatic hypertrophy (BPH) and the patient was reassessed by flexible cystoscopy revealing a large occlusive 80cc prostate. Baseline symptoms of BPH were measured using the International Prostate Symptom Score (IPSS), urinary function was quantified by measuring post void residual (PVR) volume and QMAX flow rates were also recorded. The patient underwent the Urolift procedure and urological parameters were reassessed at 4 months post-operatively. There was an improvement in the patients IPSS by 14 points (IPSS Before =22, at 4 months =8), with a reduction in quality of life by 3 points (QoL before = 5, at 4 months =2).PVR volume decreased by almost a third (29.4 %) (Before = 390ml, at 4 months = 275 ml) and QMAX improved by 8 ml/s (Before =14ml/s, at 4 months= 22ml/s). The patient reported a slight improvement in sexual function (IIEF-5 Before = 14, at 4 months = 15) and was very satisfied with the result. The improvement in IPSS, PVR volume and QMAX show Urolift is an appropriate treatment for symptomatic BPH.http://jomh.org/index.php/JMH/article/view/59 |
| spellingShingle | Antonio Devanti Bardoli Will Taylor Wasim Mahmalji Jon Cobley Is There a Minimally Invasive Day Case Operation to Treat LUTS Secondary to BPH and Avoid Sexual Dysfunction? UroLift A Case Report Journal of Men's Health |
| title | Is There a Minimally Invasive Day Case Operation to Treat LUTS Secondary to BPH and Avoid Sexual Dysfunction? UroLift A Case Report |
| title_full | Is There a Minimally Invasive Day Case Operation to Treat LUTS Secondary to BPH and Avoid Sexual Dysfunction? UroLift A Case Report |
| title_fullStr | Is There a Minimally Invasive Day Case Operation to Treat LUTS Secondary to BPH and Avoid Sexual Dysfunction? UroLift A Case Report |
| title_full_unstemmed | Is There a Minimally Invasive Day Case Operation to Treat LUTS Secondary to BPH and Avoid Sexual Dysfunction? UroLift A Case Report |
| title_short | Is There a Minimally Invasive Day Case Operation to Treat LUTS Secondary to BPH and Avoid Sexual Dysfunction? UroLift A Case Report |
| title_sort | is there a minimally invasive day case operation to treat luts secondary to bph and avoid sexual dysfunction urolift a case report |
| url | http://jomh.org/index.php/JMH/article/view/59 |
| work_keys_str_mv | AT antoniodevantibardoli isthereaminimallyinvasivedaycaseoperationtotreatlutssecondarytobphandavoidsexualdysfunctionuroliftacasereport AT willtaylor isthereaminimallyinvasivedaycaseoperationtotreatlutssecondarytobphandavoidsexualdysfunctionuroliftacasereport AT wasimmahmalji isthereaminimallyinvasivedaycaseoperationtotreatlutssecondarytobphandavoidsexualdysfunctionuroliftacasereport AT joncobley isthereaminimallyinvasivedaycaseoperationtotreatlutssecondarytobphandavoidsexualdysfunctionuroliftacasereport |